Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Eisai Neurology

Eisai Neurology
$65.66 SHARE PRICE (As of Friday Closing)

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Stock Exchange
Primary Office
  • 4-6-10 Koishikawa
  • Bunkyo-ku
  • Tokyo, 112-8088
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Eisai Neurology’s full profile, request a free trial.

Eisai Neurology Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$48.60 - $92.89 $18.8B $65.56 $1.83 1.41M 286M

Eisai Neurology Financials Summary

In Thousands,
FY 2019
FY 2018
FY 2017
Enterprise Value 13,846,494 15,148,788 18,286,446 14,930,592
Revenue 5,742,903 5,797,924 5,413,061 4,975,442
EBITDA 903,745 1,019,129 932,731 789,541
Net Income 524,543 571,698 467,691 363,253
Total Assets 9,357,028 9,663,824 9,871,381 9,219,153
Total Debt 1,069,154 1,252,693 1,629,257 1,909,311
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eisai Neurology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
Debt Status

This information is reserved for PitchBook Platform users. To explore Eisai Neurology‘s full profile, request access.

Request full access to PitchBook

Eisai Neurology Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott India Corporation Mumbai, India 0000
00000 Corporation Hatfield, United Kingdom 00000 00.00 000000&0 00.00
000000000 Private Equity-Backed Milan, Italy 0000 000000000000
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
00000000 000000000 Corporation Gaithersburg, MD 0000 000.00 000000000 000.00
To view this company’s complete list of competitors, request access »

Eisai Neurology Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000 0000000 01-Apr-2016 00000 0000000 Drug Discovery 0000 000000
00000 (00000000) 0 28-Dec-2015 000000000000000000 000.00 Drug Discovery 0000 000000
00000 06-Jan-2010 000000000000000000 00000 Biotechnology 00000 00000
000 000000 07-Dec-2007 000000000000000000 00.00 Pharmaceuticals 00000 00000
BioArctic (Alzheimer's disease drug) 01-Dec-2007 Corporate Asset Purchase Other Pharmaceuticals and Biotechnology
To view this company’s complete investment and acquisition history, request access »

Eisai Neurology Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 06-Jan-2010 000000000000000000 00000 Completed
  • 00000 000000000
00000 01-Oct-2007 0000 000.00 Completed
  • 00000 000000000
EIDIA 18-Oct-1990 Merger/Acquisition 000.00 Completed
To view this company’s complete exits history, request access »

Eisai Neurology Subsidiaries (1)

Company Name Industry Location Founded
000000000 Drug Discovery Exton, PA 0000
To view this company’s complete subsidiary history, request access »

Eisai Neurology Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Eisai Neurology‘s full profile, request access.

Request full access to PitchBook

Eisai Neurology Executive Team (7)

Name Title Board
Haruo Naito Board Member, Representative Corporate Officer & Chief Executive Officer
Ivan Cheung Chief Executive Officer & Chairman
Shaji Procida Chief Operating Officer, President and Commercial Head of the Oncology Business Group, Americas
Lihua Yu Ph.D President & Chief Data Sciences Officer
Alton Kramer MD Chief Medical Officer & Group Oncology Business, Chief Clinical Officer
You’re viewing 5 of 7 executives. Get the full list »

Eisai Neurology Board Members (2)

Name Representing Role Since Contact
0000 000000 Eisai Neurology Chief Executive Officer & Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »